ZEVIA PBC

Investor Kanen Wealth Management, which holds about 4% of outstanding shares, urged Zevia’s board to promptly evaluate strategic alternatives, up to and including a sale. Kanen estimates a potential takeover value of $2.75–$3.75 per share and points to higher valuation multiples at peers such as Poppi and Olipop. It criticizes management for missed growth and questions the CEO appointment, after which the stock gained 6.9% in premarket trading. » More on de.investing.com

Zevia posted Q2 net sales of $45 million, up 1.1%, and adjusted EBITDA of about $0.5 million versus $0.2 million a year earlier. Management maintained full-year 2026 guidance of $170–175 million in sales and an adjusted EBITDA loss of $2–4 million, while flagging continued pressure from aluminum and fuel costs. The company is prioritizing expansion of its singles platform—estimating an ~$80 million opportunity if singles match multipack share—and plans to begin executing a revised go-to-market strategy in early 2027. Zevia expects $3–5 million of annualized cost savings starting Q1 2027 and projects Q3 sales of $44–46 million with a Q3 adjusted EBITDA loss of $3–3.5 million. » More on finance.yahoo.com

Zevia reported Q2 2026 net revenue of $45.0 million, topping analyst estimates, but posted an adjusted loss of $0.04 per share, $0.01 worse than expected. Adjusted EBITDA improved to about $0.5 million, and management reaffirmed full-year guidance of $170–175 million in revenue and adjusted EBITDA of -$2 million to -$4 million. For Q3 the company expects revenue of $44–46 million and adjusted EBITDA of -$3.0 to -$3.5 million; it is continuing to invest in new packaging, flavors and a Cardi B campaign. The stock came under pressure in after-hours trading as investors weighed the earnings miss and the prospect of negative EBITDA next quarter. » More on de.investing.com

Riverwater's Micro Opportunities Strategy bought Zevia in early May as fundamentals improved toward positive EBITDA but exited the position at a modest gain after the CEO resigned in mid‑June, per a pre‑announced sell rule. The fund met Zevia's successor, who has experience from Celsius, and left the company on its watch list. Zevia closed at $1.50 on July 23 with a market cap of $107.66 million and has lost about 54% over the past 52 weeks. » More on finance.yahoo.com

Zevia reported mixed first-quarter results with revenue down about 10% year‑over‑year and adjusted EBITDA below expectations. Analyst Dana Telsey cut her price target to $3 from $5 but kept a Market Perform rating, citing near‑term execution concerns. Management lowered full‑year net sales guidance to $158–166 million and forecast Q2 revenue of $38–40 million versus analyst consensus of $46.33 million, saying improvements in go‑to‑market and operations are needed. » More on finance.yahoo.com